Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;76(12):1221-6.
doi: 10.1007/s40265-016-0616-x.

Obeticholic Acid: First Global Approval

Affiliations
Review

Obeticholic Acid: First Global Approval

A Markham et al. Drugs. 2016 Aug.

Abstract

Obeticholic acid (Ocaliva(TM)) is a farnesoid-X receptor (FXR) agonist that is being developed by Intercept Pharmaceuticals for the treatment of various liver diseases, and has recently been granted accelerated approval in the USA for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults with an inadequate response to ursodeoxycholic acid, or as monotherapy in adults unable to tolerate ursodeoxycholic acid. The drug is in preregistration for this indication in the EU. This article summarizes the milestones in the development of obeticholic acid leading to this first approval for primary biliary cholangitis.

PubMed Disclaimer

References

    1. Gastroenterology. 2013 Sep;145(3):574-82.e1 - PubMed
    1. Gastroenterology. 2015 Apr;148(4):751-61.e8 - PubMed
    1. J Med Chem. 2002 Aug 15;45(17 ):3569-72 - PubMed
    1. Aliment Pharmacol Ther. 2015 Jan;41(1):54-64 - PubMed
    1. Lancet. 2015 Mar 14;385(9972):956-65 - PubMed

MeSH terms

LinkOut - more resources